key: cord-0787019-v5dhu6tn authors: Tammaro, Antonella; Parisella, Francesca Romana; Adebanjo, Ganiyat Adenike Ralitsa title: Cutaneous long COVID date: 2021-06-26 journal: J Cosmet Dermatol DOI: 10.1111/jocd.14291 sha: 62210ffbffd8cb290fdaea80d11da5f416a411be doc_id: 787019 cord_uid: v5dhu6tn Researchers have defined the term 'long covid' as the inability to recover from the symptoms associated to COVID-19 even after months from the peak of the disease1 . Fatigue, myalgia, chest pain, shortness of breath, cardiac problems, like post-viral myocarditis, and diarrhea have been reported1 . Recently, Huang et al.2 have described the long-term outcomes of the SARS-CoV-2 infection in patients who were previously hospitalized because of COVID-19: the majority of them presented myasthenia, fatigue and pulmonary diffusion abnormalities. In a scenario that is evolving very quickly, there is the need to elucidate the manifestations of COVID-19 and "long COVID" involving the integumentary system. Emerging evidence supports the idea of a cutaneous "long COVID": As a matter of fact, a paper published by Mehta et al 3 observed the persistence of chilblain lesions during post-COVID follow-up visits. Moreover, there is international evidence describing persistence of pernio, papulosquamous eruptions, and livedo reticularis in patients weeks after the peak of the disease. 4 Notably, one patient presented with livedo reticularis and pernio for more than 5 months after the initial coronavirus infection. 4 In our clinic, we have observed a group of adult patients who had COVID-19 who referred to us because of persisting cutaneous lesions, which had appeared during the disease peak. Of note, these patients were both individuals who had been hospitalized because of a severe symptomatology and people who had been followed up at home because of mild complaints. The lesions that we observed Long covid: how to define it and how to manage it 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy Long COVID in the skin: a registry analysis of COVID-19 dermatological duration COVID-19 and its sequelae: a platform for optimal patient care, discovery and training The long tail of Covid-19" -the detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients A review of persistent post-COVID syndrome (PPCS)